Clinical trial
Oral Contraceptives in the Metabolic Syndrome
NCT00205504 · Virginia Commonwealth University, Other · Completed
Key facts
| NCT number | NCT00205504 |
|---|---|
| Title | Oral Contraceptives in the Metabolic Syndrome |
| Official title | Oral Contraceptives in the Metabolic Syndrome |
| Lead sponsor | Virginia Commonwealth University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome X, Insulin Resistance, Obesity, Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | Ortho Tri Cyclen |
| Enrollment | 46 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 8, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: